Activating mutations in ALK provide a therapeutic target in neuroblastoma by George Rani E, Sanda Takaomi, Hanna Megan, Fröhling Stefan, Luther William, Zhang Jianming, Ahn Yebin, Zhou Wenjun, London Wendy B, McGrady Patrick, Xue Liquan, Zozulya Sergey, Gregor Vlad E, Webb Thomas R, Gray Nathanael S, Gilliland D Gary, Diller Lisa, Greulich Heidi, Morris Stephan W, Meyerson Matthew, Look A Thomas in Nature (2008).

[PMID: 18923525] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.